Source: Annual Congress 2008 - Cough and airway hyperresponsiveness
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Terzano, A. Petroianni, V. Conti, D. Ceccarelli, S. Morano, A. Gatti, E. Mandosi, M. Fallarino, A. Lenzi (Rome, Italy). Insulin therapy increases airway responsiveness in type 2 diabetes patients. Eur Respir J 2008; 32: Suppl. 52, 1092

Member's Comments

No comment yet.

Related content which might interest you: Inhaled insulin does not induce immediate airway responsiveness in patients with type 1 diabetes mellitus Source: Eur Respir J 2005; 26: Suppl. 49, 582s Year: 2005 Inadequate glucose control in type 2 diabetes is associated with impaired lung function and with systemic inflammation Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 The conjunctival microcirculation disturbances at COPD patients in combination with diabetes mellitus type 2 and their correction by gliclazide Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004 Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Plasma leptin in asthma patients with steroid induced diabetes compared with obesity patients Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007 Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Death rate of COPD patients and combination with type 2 diabetes Source: Eur Respir J 2007; 30: Suppl. 51, 79s Year: 2007 Effect of inhaled human insulin (EXUBERA®; EXU) vs subcutaneous insulin (SC) on lung lining fluid constituents in adults with type 1 diabetes mellitus (T1DM) Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II Year: 2007 Type 2 diabetes-related “pulmonary insulin resistance” as a novel mechanism that complicates COPD phenotypes in mice Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Study of pulmonary function in type2 diabetes mellitus and its changes with change in duration and glycemic control Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights Year: 2012 Pulmonary function of inhaled human insulin (Exubera®) in patients with type 2 diabetes: results from a 2-year study using standardized methodology Source: Eur Respir J 2006; 28: Suppl. 50, 742s Year: 2006 Relative risk of type 2 diabetes mellitus complications is increased in non effectively treated OSA patients Source: Eur Respir J 2005; 26: Suppl. 49, 39s Year: 2005 Pulmonary function of inhaled human insulin (Exubera®) in patients with type 1 diabetes: results from a 2-year study using standardized methodology Source: Eur Respir J 2006; 28: Suppl. 50, 613s Year: 2006 Effect of roflumilast (ROF) on glucose levels in patients with COPD and diabetes mellitus type 2 (DM2) Source: Annual Congress 2010 - COPD: management Year: 2010 Exercise tolerance and ventilatory response in patients with type-1 diabetes Source: International Congress 2016 – Clinical exercise physiology in health and disease Year: 2016 Altered exercise capacity in children with type 1 diabetes Source: Virtual Congress 2021 – Respiratory physiology and breathing during sleep in health and sickness Year: 2021 Evidence of early abnormal airways’ inflammation in children with type 1 diabetes Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches Year: 2021 Respiratory muscle function in type 2 diabetes mellitus Source: Annual Congress 2008 - Assessment of the respiratory system Year: 2008 Airway hyperresponsiveness to mannitol improves in both type 2 low and type 2 high asthma after specialist management Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 Association between continuous positive airway pressure, weight change and glycaemic control in patients with type 2 diabetes Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020